Skip to main content
. 2024 Aug 7;14:1413589. doi: 10.3389/fcimb.2024.1413589

Figure 4.

Figure 4

The incidences of LLV in different subgroups by the identified high-risk factors. IT, immune tolerance (defined as normal ALT, positive HBeAg and HBV DNA ≥ 6 Log10 IU/mL); LLV, low-level viremia; PLT, platelet; LSM, liver stiffness measurement.